tion for 30 s after the injection. Using this procedure, >95% of the mice retained the TNBS enema. If an animal quickly excreted the TNBS-ethanol solution, it was excluded from the remainder of the study. KP MeOH extract (10 and 20 mg/kg), KP BuOH fraction (10 and 20 mg/kg) or kalopanaxsaponin B (10 and 20 mg) or vehichle alone was orally administered once a day for 3 days after TNBS treatment. Test agents were dissolved in 2% tween 80 solution. The mice were anesthetized with ether and sacrifi ced. The colon was quickly removed, opened longitudinally, and gently cleared of stool by PBS. Macroscopic assessment of the disease grade was scored according to a previously reported scoring system (0, no ulcer and no infl ammation; 1, ulceration without hyperemia; 2, ulceration and local hyperemia; 3, ulceration and infl ammation at one site only; 4, two or more sites of ulceration and infl ammation; 5, ulceration extending more than 2 cm, and the colon tissue was then used for ELISA and immunoblotting.
For the histological exam, the colons were fi xed in 10%-buffered formalin solution, embedded in paraffi n using standard methods, cut into 5-μm sections, stained with hematoxylineosin, and then assessed under light microscopy.
Colon tissue preparation
The colon tissues were excised, perfused with ice-cold perfusion solution (0.15 M KCl, 2 mM EDTA, pH 7.4), and homogenized in 50 mM Tris-HCl buffer (pH 7.4). The homogenates were centrifuged at 10,000 × g at 4 o C for 30 min. The supernatant was used for the estimation of antioxidant defense system.
Assay of myeloperoxidase activity
An aliquot (50 μl) of the colon supernatant was added to a reaction mixture of 1.6 mM tetramethyl benzidine and 0.1 mM H 2 O 2 and incubated at 37 o C; the absorbance was obtained at 650 nm over time . Myeloperoxidase activity was defi ned as the quantity of enzyme degrading 1 μmol/ml of peroxide at 37 o C and expressed in unit/mg protein. The protein content was assayed by the method of Bradford (1976) .
ELISA and immunoblot
For the ELISA of IL-1β, IL-6, IL-10 and TNF-α, colons or cell-cultured supernatants were homogenized in 1 ml of icecold RIPA lysis buffer containing 1% protease inhibitor cocktail and 1% phosphatase inhibitor cocktail. 
Isolation of kalopanaxsaponin B
The dried stem-bark of KP (2 kg) was extracted fi ve times with MeOH under heating. The MeOH extracts were combined and evaporated to dryness under reduced pressure, which yielded 72 g. The dried extract was suspended in distilled water and extracted with EtOAc (5.3 g) and BuOH (9 g), successively. Kalopanaxsaponin B (420 mg; purity, >95%) was isolated from KP BuOH fraction (9 g) according to the previous method of Joh et al. (2012) .
Animals
Male ICR mice (specifi c pathogen-free, 20-25 g, 5 weeksold) were supplied by Orient Experimental Animal Breeding Center (Seoul, Korea) and housed in wire cages at 20-22 o C and 50 ± 10% humidity, fed standard laboratory chow (Samyang, Seoul, Korea) and allowed water ad libitum. 
Isolation and culture of peritoneal macrophages
Male ICR mice were intraperitoneally injected with 2 ml of 4% sodium thioglycolate solution. Mice were sacrifi ced 4 days after injection and the peritoneal cavities were fl ushed with 10 ml of RPMI 1640. The peritoneal lavage fl uids were centrifuged at 500× g for 10 min and the cells were resuspended with RPMI 1640 and plated. After incubation for 2 h at 37 o C, the cells were washed three times and nonadherent cells were removed by aspiration. Cells were cultured in 24-well plates (0.5×10 6 cells/well) at 37 o C in RPMI 1640 plus 10% FBS. The attached cells were used as peritoneal macrophages. To examine the anti-infl ammatory effect of KP water extract, KP MeOH extract and KP BuOH fraction, peritoneal macrophages were incubated in the absence or presence of kalopanaxsaponin B with 50 ng/ml LPS. The cytoxicity of these agents in the cell viability was measured using the crystal violet method.
Preparation of experimental colitic mice
The mice were randomly divided into 7 groups for the evaluation of anti-colitic effect of KP extracts (normal and TNBS-induced colitic groups treated with or without KP MeOH extract, KP BuOH fraction or sulfasalazine) and 5 groups for that of kalopanaxsaponin B (normal and TNBS-induced colitic groups treated with or without kalopanaxsaponin or sulfasalazine). Each group is consisted of 6 mice. TNBS-induced colitis was induced by the administration of 2.5% (w/v) TNBS solution (100 μl) in 50% ethanol into the colon of lightly anesthetized mice via a thin round-tip needle equipped with a 1-ml syringe . The normal group was treated with vehicle alone. The needle was inserted so that the tip was 3.5-4 cm proximal to the anal verge. To distribute the agent within the entire colon and cecum, mice were held in a vertical posi-www.biomolther.org was transferred to 96-well ELISA plates. IL-1β, IL-6, IL-10 and TNF-α concentrations were determined using commercial ELISA kits (Pierce Biotechnology, Inc., Rockford, IL, USA) .
For the immunoblot analyses of p-IRAK1, p-IKKβ, p-p65 and β-actin, the colon tissue homogenates or the colleted cells were resuspended in 1 ml of RIPA lysis buffer containing 1% protease inhibitor cocktail and 1% phosphatase inhibitor cocktail. After centrifugation, the supernatant was used for the immunoblot assay. The proteins from collected cells were subjected to electrophoresis on 8-10% sodium dodecyl sulfate-polyacrylamide gel and then transferred to nitrocellulose membrane. Levels of p-IRAK1, p-IKKβ, p-p65 and β-actin were assayed as previously described . Immunodetection was performed using an enhanced chemiluminescence detection kit.
Statistical analysis
All data are expressed as the mean ± standard deviation, with statistical signifi cance analyzed using one-way ANOVA followed by a Student-Newman-Keuls test.
RESULTS AND DISCUSSION
During a screening program to evaluate the anticolitic activities of herbal medicines, KP water extract was found to inhibit NF-κB activation in LPS-stimulated peritoneal macrophages (Fig. 1) . To isolate active component(s), we extracted it with MeOH and prepared its BuOH fraction and then investigated their inhibitory effects against the expression of proinfl ammatory cytokines in LPS-stimulated peritoneal macrophages (Fig.  2) . LPS increased TNF-α, IL-1β and IL-6 expression and NF-κB activation. However, treatment with LPS in the presence of KP water, MeOH or BuOH extract reduced TNF-α, IL-1β and IL-6 expression and NF-κB activation. Of them, KP BuOH extract most potently inhibited the expression of proinfl ammatory cytokines and the activation of NF-κB.
Next we tested the ability of KP MeOH and its BuOH fraction to inhibit TNBS-induced colitis in mice. Intrarectal injection of TNBS caused signifi cant colitis in mice (Fig. 3) . TNBS caused severe infl ammation, manifested by shortened, thickened, and erythematous colons. TNBS increased myeloperoxidase activity. Treatment with KP MeOH extract or BuOH fraction in TNBS-induced colitic mice inhibited colon shortening and myeloperoxidase activity. We also measured their inhibitory effects on the pro-infl ammatory cytokines, TNF-α, IL-1β, and IL-6 in the colons of TNBS-induced colitic mice (Fig.  4) . TNBS increased protein expression of IL-1β IL-6 and TNF-α in mice, respectively. KP MeOH and BuOH extracts inhibited the expression of these proinfl ammatory cytokines and the activation of NF-κB. KP BuOH extract at a dose of 20 mg/ kg inhibited TNBS-induced TNF-α, IL-1β, and IL-6 expression by 72%, 81% and 98%, respectively. However, it reversed IL-10 to 69% of the normal control group. TNBS also phosphorylated IRAK1, IKKβ and p-65. KP BuOH potently inhibited their phosphorylations.
To ensure the anticolitic effect of KP BuOH fraction, we isolated kalopanaxsaponin B, a main constituent of KP BuOH fraction (Joh et al., 2012) , in TNBS-induced colitic mice (Fig.   Fig. 5 . The effects of kalopanaxsaponin B (KB) on colon length (A), macroscopic disease (B), colonic myeloperoxidase activity (C) and histology (D) in TNBS-induced colitic mice. TNBS was intrarectally administered in TNBS, KB (10 and 20 mg/kg) and S (50 mg/ kg) groups. Test agents (suspended in 2% Tween 80) were orally administered once a day for 3 days after TNBS treatment. Normal and TNBS groups were treated with vehicle alone. The mice were anesthetized with ether and sacrifi ced 12 h after the fi nal administration of test agents. The colons were stained with hematoxylineosin and then assessed by light microscopy. All values are the mean ± S.D. (n=6).
# Significantly different vs. normal group (p<0.05). *Signifi cantly different vs. group treated with TNBS alone (p<0.05). www.biomolther.org 5). TNBS caused severe colonic infl ammation, including colon shortening, increased myeloperoxidase activity and proinfl ammatory cytokine expression, and NF-kB activation. Treatment with kalopanaxsaponin B in TNBS-induced colitic mice inhibited colon shortening and myeloperoxidase activity. Furthermore, kalopanaxsaponin B (10 mg/kg) inhibited TNF-α, IL-1β, and IL-6 expressions by 86%, 98% and 97%, respectively (Fig. 6) . Kalopanaxsaponin B inhibited the expression of COX-2 and iNOS and the activation of NF-κB. Anti-colitic effect of kalopanaxsaponin B was comparable to that of sulfasalazine.
TNBS, a colitis inducer, induces gram-negative bacteria, such as Enterobacteriaceae, in the intestine of mice (Lee et al., 2010a) . Gram-negative bacteria produce endotoxins, such as LPS. LPS increases serum IL-1β and TNF-α levels and causes infl ammation, although blood IL-1β and TNF-α levels are barely detectable in mice without any stimuli or treatment (Blanqué et al., 1996; Ingalls et al., 1999) . Suppression of IL-1β and/or TNF-α productions by other constituents, such as luteolin, quercetin, ginsenosides, berberine and kalopanaxsaponin A are suggested to ameliorate several infl ammatory disorders, including endotoxemia, colitis, sand rheumatoid arthritis (Huang et al., 1999; Kotanidou et al., 2002; Lee et al., 2010b) . Their potential mechanisms have been suggested to inhibit signal transduction pathways, such as the activation of NF-κB.
In the present study, KP extracts exhibited anti-infl ammatory effects in LPS-induced peritoneal macrophages, like the previously reported . Of KP extracts, KP BuOH extract showed the most potent inhibition against LPS-stimualted peritoneal macrophages and TNBS-induced murine colitis. Furthemore, kalopanaxsaponin B, a main constituent of KP, potently inhibited LPS-stimulated infl ammation in peritoneal macrophages and TNBS-induced colitis in mice, like kalopanaxsaponin A. It is suggested that kalopanaxsaponin A may exhibit more potent anti-infl ammatory effect than kalopanaxsaponin B . Nevertheless, anticolitic effect of KP extracts may be dependent on kalopanaxsaponins, particularly kalopanaxsaponin B. Because kalopanaxsaponin B is a major constituent in KP and, if orally administered, it is partially metabolized to kalopanaxsaponin A in the intestine by intestinal microfl ora.
Based on these fi ndings, KP, particularly its main constituent, kalopanaxsaponin B, may ameliorate colitis by inhibiting NF-κB pathway. Fig. 6 . The effect of kalopanaxsaponin B (KB) on the expression of pro-infl ammatory cytokines (A), COX-2 and iNOS and the activation of NF-κB (B) in TNBS-induced colitic mice. TNBS was intrarectally administered in TNBS, KB (10 and 20 mg/kg) and S (50 mg/ kg) groups. Test agents (suspended in 2% Tween 80) were orally administered once a day for 3 days after TNBS treatment. Normal and TNBS groups were treated with vehicle alone. The mice were anesthetized and sacrificed 12 h after the final administration of test agents. Levels of IL-1β, TNF-α and IL-6 in the colon homogenate were measured by ELISA. p-IRAK1, p-IKKβ, p-p65 and β-actin were measured by immunoblotting. All values are the mean ± S.D. (n=6).
# Signifi cantly different vs. normal (N) group (p<0.05). *Signifi cantly different vs. control (C) group (p<0.05).
